Articles in Scholarly Journals [Incomplete List]

1. Significance of ammonium compounds on nicotine exposure to cigarette smokers
   Food and Chemical Toxicology, vol. 44, no. 5, pp. 678–688, 2006
2. Sugars as tobacco ingredient: Effects on mainstream smoke composition
   Food and Chemical Toxicology, vol. 44, no. 11, pp. 1789–1798, 2006
3. Tobacco usage interacts with postdisaster psychopathology on circadian salivary cortisol
   International Journal of Psychophysiology, vol. 59, no. 3, pp. 251–258, 2006
4. Contribution of monoamine oxidase (MAO) inhibition to tobacco and alcohol addiction
   Life Sciences, vol. 79, no. 21, pp. 1969–1973, 2006
5. The Effect of Vitamin E Supplementation on Serum DHEA and Neopterin Levels in Elderly Subjects
   International Journal for Vitamin and Nutrition Research, vol. 075, no. 05, pp. 0327–0331, 2005
6. Exhaled nitric oxide predicts airway hyper-responsiveness to hypertonic saline in children that wheeze
   Allergy, vol. 60, no. 12, pp. 1499–1504, 2005
7. Evaluation of a procedure to assess the adverse effects of illicit drugs
   Regulatory Toxicology and Pharmacology, vol. 39, no. 1, pp. 1–4, 2004
8. The Prevalence of Allergic Sensitisation in Immigrant Children in the Netherlands
   International Archives of Allergy and Immunology, vol. 133, no. 3, pp. 248–254, 2004
9. Acute Effect of Air Pollution on Respiratory Complaints, Exhaled NO and Biomarkers in Nasal Lavages of Allergic Children during the Pollen Season
   International Archives of Allergy and Immunology, vol. 131, no. 2, pp. 127–137, 2003
10. Relationship between exhaled NO, respiratory symptoms, lung function, bronchial hyperresponsiveness, and blood eosinophilia in school children
    Thorax, vol. 58, no. 3, pp. 242–245, 2003
11. Flow dependency and off-line measurement of exhaled NO in children
    Pediatric Allergy and Immunology, vol. 14, no. 4, pp. 266–271, 2003
12. The relationship between exhaled nitric oxide and allergic sensitization in a random sample of school children
    Clinical Experimental Allergy, vol. 33, no. 2, pp. 187–191, 2003
13. Circadian Variation in Cortisol Reactivity to an Acute Stressor
    Chronobiology International, vol. 20, no. 5, pp. 863–878, 2003
14. Association between exhaled nitric oxide, ambient air pollution and respiratory health in school children
    International Archives of Occupational and Environmental Health, vol. 75, no. 5, pp. 348–353, 2002
15. A Simple Method to Sample Exhaled NO Not Contaminated by Ambient NO from Children and Adults in Epidemiological Studies
    Nitric Oxide, vol. 4, no. 2, pp. 168–174, 2000
16. The Effect of Air Pollution on Exhaled Nitric Oxide of Atopic and Nonatopic Subjects
    Nitric Oxide, vol. 3, no. 6, pp. 492–495, 1999
17. The balloon technique: a convenient method to measure exhaled NO in epidemiological studies
    International Archives of Occupational and Environmental Health, vol. 72, no. 6, pp. 404–407, 1999
18. Increased exhaled nitric oxide on days with high outdoor air pollution is of endogenous origin
    European Respiratory Journal, vol. 13, no. 2, pp. 334–337, 1999
19. Nitric oxide and biopterin in depression and stress
    Psychiatry Research, vol. 85, no. 1, pp. 33–38, 1999
20. The effect of pertussis toxin and whole-cell pertussis vaccine on haemodynamics and autonomic responsiveness in the rat depends on route of administration and age
    Vaccine, vol. 16, no. 7, pp. 666–671, 1998
21. Repeated administration of whole-cell and acellular pertussis vaccines affects haemodynamics and autonomic responsiveness
    Vaccine, vol. 16, no. 17, pp. 1668–1674, 1998
22. Effect of L-NAME, an inhibitor of nitric oxide synthesis, on plasma levels of IL-6, IL-8, TNF? and nitrite/nitrate in human septic shock
    Intensive Care Medicine, vol. 24, no. 7, pp. 673–679, 1998
23. ACE Inhibitor???Induced Angioedema
    Drug Safety, vol. 18, no. 3, pp. 171–188, 1998
24. Suppression of Cytochrome P450- and UDP Glucuronosyl Transferase-Dependent Enzyme Activities by Proinflammatory Cytokines and Possible Role of Nitric Oxide in Primary Cultures of Pig Hepatocytes
    Toxicology and Applied Pharmacology, vol. 137, no. 2, pp. 237–244, 1996
25. Effect of septicaemia on the plasma levels of biopterin and nitric oxide metabolites in rats and rabbits
    Biochemical Pharmacology, vol. 52, no. 9, pp. 1447–1451, 1996
26. Cyclic AMP enhancing drugs modulate eicosanoid release from human alveolar macrophages
    Life Sciences, vol. 54, no. 17, pp. 1269–1274, 1994
27. Cyclic-AMP level and eicosanoid release from alveolar macrophages are differentially affected by high and low dose of platelet activating factor
    Biochemical Pharmacology, vol. 47, no. 3, pp. 588–590, 1994
28. Septic shock: no correlation between plasma levels of nitric oxide metabolites and hypotension or lethality
    European Journal of Pharmacology: Environmental Toxicology and Pharmacology, vol. 270, no. 4, pp. 379–382, 1994
29. Modulation by pertussis toxin of salbutamol- and arecoline-induced effects in the isolated heart and aorta of the rat
    European Journal of Pharmacology, vol. 250, no. 3, pp. 415–422, 1993
30. Tetrahydrobiopterin induces vasodilation via enhancement of cGMP level
    European Journal of Pharmacology, vol. 230, no. 3, p. 387, 1993
31. Pulmonary granulocyte influx and impaired alveolar macrophage adenylyl cyclase responsiveness in developing respiratory distress
    Mediators of Inflammation, vol. 2, no. 3, pp. 247–251, 1993
32. Stimulation of cyclic AMP production in human alveolar macrophages induced by inflammatory mediators and ß-sympathicomimetics
    European Journal of Pharmacology: Environmental Toxicology and Pharmacology, vol. 228, no. 1, pp. 57–62, 1992
33. Tetrahydrobiopterin induces vasodilatation via enhancement of cGMP level
    European Journal of Pharmacology, vol. 215, no. 2-3, pp. 349–350, 1992
34. Sensitization enhances the adenylyl cyclase responsiveness in alveolar macrophages Changes induced at post-receptor level
    Biochemical Pharmacology, vol. 42, no. 3, pp. 485–490, 1991
35. Identification of? 2-adrenoceptors on guinea pig alveolar macrophages using (?)-3-[125I]iodocyanopindolol
    Inflammation, vol. 14, no. 4, pp. 421–426, 1990
36. Adenyl cyclase activity in human alveolar macrophages
    European Journal of Pharmacology, vol. 183, no. 4, pp. 1182–1183, 1990
37. Enkephalin biosynthesis and release in mouse striatum are inhibited by GABA receptor stimulation: compared changes in preproenkephalin mRNA and Tyr-Gly-Gly levels
    Molecular Brain Research, vol. 8, no. 3, pp. 227–233, 1990
38. Antigen challenge modifies the cyclic AMP response of inflammatory mediators and ß-adrenergic drugs in alveolar macrophages
    European Journal of Pharmacology, vol. 174, no. 1, pp. 33–41, 1989
39. Inhibition of enkephalin degradation by phelorphan: effects on striatal [Met5]enkephalin levels and jump latency in mouse hot plate test
    European Journal of Pharmacology, vol. 154, no. 3, pp. 319–324, 1988
40. Effect of inhibitors of enkephalin degradation in the isolated guinea-pig ileum
    Life Sciences, vol. 43, no. 19, pp. 1529–1536, 1988
41. Synthesis of enkephalinase B inhibitors, and their activity on isolated enkephalin-degrading enzymes
    European Journal of Pharmacology, vol. 135, no. 3, pp. 411–418, 1987
42. Effect of various enkephalin analogs and dipeptides on the enzymatic activity of enkephalinase B isolated from calf-brain striatum
    Life Sciences, vol. 38, no. 12, pp. 1111–1118, 1986
43. Isolation and characterization of an enkephalin-hydrolyzing dipeptidyl-aminopeptidase from calf-brain striatum
    Neuropeptides, vol. 6, no. 5, pp. 381–389, 1985
44. Determination of leu-enkephalin degradation by a soluble enzyme preparation from calf-brain striatum using reversed-phase high-performance liquid chromatography
    Journal of Chromatography A, vol. 258, pp. 165–174, 1983
45. Inhibitors of calf-brain enkephalinase A and B
    Life Sciences, vol. 33, pp. 109–112, 1983